• Login
• Admin

2018

Abo-zeid, Yasmin, Urbanowicz, Richard A., Thomson, Brian J., Irving, William L., Tarr, Alexander W. and Garnett, Martin C. (2018) Enhanced nanoparticle uptake into virus infected cells: could nanoparticles be useful in antiviral therapy? International Journal of Pharmaceutics, 547 (1-2). pp. 572-581. ISSN 1873-3476

Abo-zeid, Yasmin, Mantovani, Giuseppe, Irving, William L. and Garnett, Martin.C (2018) Synthesis of nucleoside-boronic esters hydrophobic pro-drugs: a possible route to improve hydrophilic nucleoside drug loading into polymer nanoparticles. Journal of Drug Delivery Science and Technology, 46 . pp. 354-364. ISSN 1773-2247

Kendall, Timothy, Dolman, Grace, Duff, Catherine, Paish, Emma C., Zaitoun, Abed, Irving, William L., Fallowfield, Jonathan A. and Guha, Indra Neil (2018) Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease. Histopathology, 73 (1). pp. 90-100. ISSN 1365-2559

Scott, Robert A., Aithal, Guruprasad P., Francis, Susan T. and Irving, William L. (2018) Pretreatment lesions on magnetic resonance imaging in patients with hepatitis C virus infection diagnosed with hepatocellular carcinoma after initiating direct-acting antiviral therapy. Gastroenterology, 154 (6). pp. 1848-1850. ISSN 0016-5085

Harris, Magdalena, Bonnington, Oliver, Harrison, Graham, Hickman, Matthew and Irving, William L. (2018) Understanding hepatitis C intervention success: qualitative findings from the HepCATT study. Journal of Viral Hepatitis . ISSN 1365-2893

Walker, Alex J., Peacock, Christian J., Pedergnana, Vincent and Irving, William L. (2018) Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: a systematic review. Journal of Viral Hepatitis, 25 (5). pp. 442-456. ISSN 1365-2893

2017

Athwal, Varinder S., Pritchett, James, Llewellyn, Jessica, Martin, Katherine, Camacho, Elizabeth, Raza, Sayyid M.A., Phythian-Adams, Alexander, Birchall, Lindsay J., Mullan, Aoibheann F., Su, Kim, Pearmain, Laurence, Dolman, Grace, Zaitoun, Abed M., Friedman, Scott L., MacDonald, Andrew, Irving, William L., Guha, Indra N., Hanley, Neil A. and Hanley, Karen Piper (2017) SOX9 predicts progression towards cirrhosis in patients while its loss protects against liver fibrosis. EMBO Molecular Medicine, 9 (12). pp. 1696-1710. ISSN 1757-4684

Manouchehrinia, Ali, Tanasescu, Radu, Kareem, Huner, Jerca, Oltita P., Jabeen, Fouzia, Shafei, Rachelle, Breuer, Judith, Neal, Keith R., Irving, William L. and Constantinescu, Cris S. (2017) Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis. Journal of NeuroVirology . pp. 1-6. ISSN 1538-2443

Hudson, Benjamin, Walker, Alex J. and Irving, William L. (2017) Comorbities and medications of patients with chronic hepatitis C under specialist care in the UK. Journal of Medical Virology, 89 (12). pp. 2158-2164. ISSN 1096-9071

McLauchlan, John, Innes, H., Dillon, J.F., Foster, G., Holtham, E., McDonald, S., Wilkes, B., Hutchinson, S.J. and Irving, William L. (2017) Cohort profile: the Hepatitis C Virus (HCV) Research UK clinical database and biobank. International Journal of Epidemiology . ISSN 1464-3685

2016

Thabet, Khaled, Asimakopoulos, Anastasia, Shojaei, Maryam, Romero-Gomez, Manuel, Mangia, Alessandra, Irving, William L., Berg, Thomas, Dore, Gregory J., Grønbæk, Henning, Sheridan, David, Abate, Maria Lorena, Bugianesi, Elisabetta, Weltman, Martin, Mollison, Lindsay, Cheng, Wendy, Riordan, Stephen, Fischer, Janett, Spengler, Ulrich, Nattermann, Jacob, Wahid, Ahmed, Rojas, Angela, White, Rose, Douglas, Mark W., McLeod, Duncan, Powell, Elizabeth, Liddle, Christopher, van der Poorten, David, George, Jacob, Eslam, Mohammed, Gallego-Duran, Rocio, Applegate, Tanya, Bassendine, Margaret, Rosso, Chiara, Mezzabotta, Lavinia, Leung, Reynold, Malik, Barbara, Matthews, Gail, Grebely, Jason, Fragomeli, Vincenzo, Jonsson, Julie R. and Santaro, Rosanna (2016) MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C. Nature Communications, 7 . 12757/1-12757/10. ISSN 2041-1723

Cheung, Michelle C.M., Walker, Alex J., Hudson, Benjamin E., Verma, Suman, McLauchlan, John, Mutimer, David J., Brown, Ashley, Gelson, William T.H., MacDonald, Douglas C., Agarwal, Kosh, Foster, Graham R. and Irving, William L. (2016) Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis. Journal of Hepatology . ISSN 0168-8278

Urbanowicz, Richard A., McClure, Patrick, Brown, Richard J.P., Tsoleridis, Theocharis, Persson, Mats A.A., Krey, Thomas, Irving, William L., Ball, Jonathan K. and Tarr, Alexander W. (2016) A diverse panel of hepatitis C virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance. Journal of Virology, 90 (7). pp. 3288-3301. ISSN 1098-5514

Foster, Graham R., Irving, William L., Cheung, Michelle C.M., Walker, Alex J., Hudson, Benjamin E., Verma, Suman, McLauchlan, John, Mutimer, David J., Brown, Ashley, Gelson, William T.H., MacDonald, Douglas C. and Agarwal, Kosh (2016) Cohort study of the impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis. Journal of Hepatology . ISSN 0168-8278 (In Press)

2014

Hamed, Mohamed R., Brown, Richard J.P., Zothner, Carsten, Urbanowicz, Richard A., Mason, Christopher P., Krarup, Anders, McClure, C. Patrick, Irving, William L., Ball, Jonathan K., Harrison, Mark, Hickling, Timothy P. and Tarr, Alexander W. (2014) Recombinant human L-ficolin directly neutralizes hepatitis C virus entry. Journal of Innate Immunity, 6 (5). pp. 676-684. ISSN 1662-8128

Lattimore, Sam, Irving, William L., Collins, Sarah, Penman, Celia and Ramsay, Mary (2014) Using surveillance data to determine treatment rates and outcomes for patients with chronic hepatitis C virus infection. Hepatology, 59 (4). pp. 1343-1350. ISSN 1527-3350

Backx, M., Lewszuk, A., White, J.R., Cole, J., Sreedharan, A., van Sanden, S., Diels, J., Lawson, A., Neal, K.R., Wiselka, M.J., Ito, T. and Irving, William L. (2014) The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy. Journal of Viral Hepatitis, 21 (3). pp. 208-215. ISSN 1365-2893

Edwards, Victoria C., McClure, Patrick, Brown, Richard J.P., Thompson, Emma, Irving, William L. and Ball, Jonathan K. (2014) Use of short-tandem repeat (STR) fingerprinting to validate sample origins in hepatitis C virus molecular epidemiology studies. Journal of General Virology, 95 (1). pp. 66-70. ISSN 1465-2099

2012

Tarr, Alexander, W., Urbanowicz, Richard, A., Jayaraj, Dhanya, Brown, Richard, J.P., McKeating, Jane, A., Irving, William L. and Ball, Jonathan, K. (2012) Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the Hepatitis C virus E2 protein confer noninterfering, additive neutralization. Journal of Virology, 86 (5). pp. 2739-2749. ISSN 0022-538X

Tarr, Alexander W., Urbanowicz, Richard A., Jayaraj, Dhanya, Brown, Richard J.P., McKeating, Jane A., Irving, William L. and Ball, Jonathan K. (2012) Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitus C virus E2 protein confer noninterfering, additive neutralization. Journal of Virology, 86 (5). pp. 2739-2749. ISSN 0022-538X